MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced the ...

Peripheral neuropathy can be a symptom of chronic Lyme disease, causing burning, tingling, and numbness in extremities ...

An impaired movement of the brain’s cerebrospinal fluid, which helps remove waste, could explain how poor sleep and heart ...

A disease that once paralysed thousands is on the brink of eradication, but the last mile requires overcoming stigma, ...

The limits of the senses remain an unknown to be discovered. Many scientists have sought answers to unravel one of humanity's ...

Eye twitching, often harmless, can sometimes signal serious neurological conditions. Conditions like Blepharospasm, ...

Demyelinating disorders of the central nervous system (CNS) — including multiple sclerosis (MS), myelin oligodendrocyte glycoprotein antibody-associated ...

A devastating neurological disorder begins showing signs of manifestation years before previously believed, marking a ...

MapLight Therapeutics Inc.’s (MPLT) Nasdaq IPO has attracted orders exceeding the available shares ahead of its scheduled pricing on October 26, according to a Bloomberg report on Monday.

By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for ...

Marcy McCann, who contracted West Nile virus in early August after helping a friend clean out her home, initially experienced ...

Golgi and Cajal's rivalry reshaped biology, leading to the birth of modern neuroscience with lasting impacts on global health ...